Feasibility Study of Ultrasound-guided Functional Remodeling of Lower Extremity Superficial Venous Valve
1 other identifier
interventional
10
1 country
1
Brief Summary
In this project, an exploratory study was conducted to perform in situ venous valve remodeling in vivo, evaluate venous valve function after surgery and conduct regular follow-up, collect relevant ultrasonic data before, during and after surgery, and evaluate the safety and effectiveness of Ultrasound-guided percutaneous great saphenous vein valve functional remodeling.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 19, 2023
CompletedFirst Submitted
Initial submission to the registry
May 24, 2023
CompletedFirst Posted
Study publicly available on registry
June 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2024
CompletedJune 22, 2023
June 1, 2023
9 months
May 24, 2023
June 19, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Venous valve regurgitation or not
Under the calf compression test, the venous valves were observed for blood flow regurgitation signal
immediately after intervention
Venous valve regurgitation or not
Under the calf compression test, the venous valves were observed for blood flow regurgitation signal
1 week after intervention
Venous valve regurgitation or not
Under the calf compression test, the venous valves were observed for blood flow regurgitation signal
1 month after intervention
Venous valve regurgitation or not
Under the calf compression test, the venous valves were observed for blood flow regurgitation signal
3 months after intervention
Venous valve regurgitation or not
Under the calf compression test, the venous valves were observed for blood flow regurgitation signal
6 months after intervention
Venous valve regurgitation or not
Under the calf compression test, the venous valves were observed for blood flow regurgitation signal
1 year after intervention
Changes in the duration of venous valve regurgitation
The duration of venous valve regurgitation was measured under calf compression test
immediately after intervention
Changes in the duration of venous valve regurgitation
The duration of venous valve regurgitation was measured under calf compression test
1 week after intervention
Changes in the duration of venous valve regurgitation
The duration of venous valve regurgitation was measured under calf compression test
1 month after intervention
Changes in the duration of venous valve regurgitation
The duration of venous valve regurgitation was measured under calf compression test
3 months after intervention
Changes in the duration of venous valve regurgitation
The duration of venous valve regurgitation was measured under calf compression test
6 months after intervention
Changes in the duration of venous valve regurgitation
The duration of venous valve regurgitation was measured under calf compression test
1 year after intervention
Study Arms (1)
Venous valve remodeling
EXPERIMENTALVenous valve function was remodeled under ultrasound guidance
Interventions
Preoperative ultrasound was used to re-evaluate and confirm the valve function, disinfect the tissue, inject hyaluronic acid around the great saphenous vein valve to reshape the valve about 1-2ml, monitor the whole process under ultrasound, pump back for protection during injection, and inject multiple times at different points.
Eligibility Criteria
You may qualify if:
- Age 18-80, gender unlimited
- CEAP grading was C2-C5 patients
- The patient was clinically diagnosed as a primary varicose great saphenous vein of lower extremity, and the ultrasound findings were great saphenous vein valve insufficiency (complete structure, normal shape, enlarged valve ring, Duration of reflux \>0.5s), only unilateral varicose great saphenous vein was treated this time
You may not qualify if:
- Patients with target vessel diameter \< 3mm
- The final valve of the great saphenous vein was not clear or lost its normal shape on ultrasound
- Patients with deep vein valvular insufficiency
- The presence of thrombus or thrombophlebitis in the main trunk of great cryptic skin
- Target diseased blood vessel had previously received surgical treatment
- Patients with deep vein thrombosis or history of pulmonary distension embolism
- Patients with active implants such as pacemakers or ICDs
- Patients with severe abnormal liver and kidney function (more than three times the normal value)
- Patients with non-primary varicose veins caused by post-deep vein thrombosis syndrome, Cockett syndrome (iliac vein compression syndrome), KT syndrome (venous malformation hypertrophy syndrome \>, arteriovenous sputum, etc
- Any serious or uncontrolled systemic disease (including poorly medicated hypertension, diabetes, and diseases with active bleeding signs or severe coagulopathy)
- Patients with diseases that may make treatment and evaluation difficult (e.g., malignant arsine tumor, acute infectious diseases, sepsis, systemic intolerability of surgery, life expectancy less than 12 months, etc.)
- Pregnant and lactating women, or those who planned to have children during the study period
- Patients who have participated in clinical trials of other drugs or medical devices within the last 3 months
- Anesthetist and other patients were deemed unsuitable for the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Fourth Affiliated Hospital Zhejiang University School of Medicine
Yiwu, Zhejiang Procince, 322000, China
Related Publications (2)
De Maeseneer MG, Kakkos SK, Aherne T, Baekgaard N, Black S, Blomgren L, Giannoukas A, Gohel M, de Graaf R, Hamel-Desnos C, Jawien A, Jaworucka-Kaczorowska A, Lattimer CR, Mosti G, Noppeney T, van Rijn MJ, Stansby G, Esvs Guidelines Committee, Kolh P, Bastos Goncalves F, Chakfe N, Coscas R, de Borst GJ, Dias NV, Hinchliffe RJ, Koncar IB, Lindholt JS, Trimarchi S, Tulamo R, Twine CP, Vermassen F, Wanhainen A, Document Reviewers, Bjorck M, Labropoulos N, Lurie F, Mansilha A, Nyamekye IK, Ramirez Ortega M, Ulloa JH, Urbanek T, van Rij AM, Vuylsteke ME. Editor's Choice - European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg. 2022 Feb;63(2):184-267. doi: 10.1016/j.ejvs.2021.12.024. Epub 2022 Jan 11. No abstract available.
PMID: 35027279RESULTMuhlberger D, Brenner E, Frings N, Geier B, Mumme A, Reich-Schupke S, Steffen HP, Stenger D, Stucker M, Hummel T. Functional repair of the great saphenous vein by external valvuloplasty reduces the vein's diameter: 6-month results of a multicentre study. J Int Med Res. 2021 May;49(5):3000605211014364. doi: 10.1177/03000605211014364.
PMID: 33990156RESULT
Study Officials
- STUDY DIRECTOR
Yuefeng Zhu, Master's
The Fourth Affiliated Hospital Zhejiang University School of Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Open trial
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2023
First Posted
June 22, 2023
Study Start
April 19, 2023
Primary Completion
December 31, 2023
Study Completion
July 30, 2024
Last Updated
June 22, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share